AAAAAA
Results: 1-25/49
Authors:
Wagner, U
Kohler, S
Reinartz, S
Giffels, P
Huober, J
Renke, K
Schlebusch, H
Biersack, HJ
Mobus, V
Kreienberg, R
Bauknecht, T
Krebs, D
Wallwiener, D
Citation: U. Wagner et al., Immunological consolidation of ovarian carcinoma recurrences with monoclonal anti-idiotype antibody ACA125: Immune responses and survival in palliative treatment, CLIN CANC R, 7(5), 2001, pp. 1154-1162
Authors:
Reles, A
Wen, WH
Schmider, A
Gee, C
Runnebaum, IB
Kilian, U
Jones, LA
El-Naggar, A
Minguillon, C
Schonborn, I
Reich, O
Kreienberg, R
Lichtenegger, W
Press, MF
Citation: A. Reles et al., Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer, CLIN CANC R, 7(10), 2001, pp. 2984-2997
Authors:
Bruning, A
Kohler, T
Quist, S
Wang-Gohrke, S
Moebus, VJ
Kreienberg, R
Runnebaum, IB
Citation: A. Bruning et al., Adenoviral transduction efficiency of ovarian cancer cells can be limited by loss of integrin beta(3) subunit expression and increased by reconstitution of integrin alpha(V)beta(3), HUM GENE TH, 12(4), 2001, pp. 391-399
Authors:
Stickeler, E
Therasakvichya, S
Moebus, VJ
Kieback, DG
Runnebaum, IB
Kreienberg, R
Citation: E. Stickeler et al., Modulation of soluble CD44 concentrations by hormone and anti-hormone treatment in gynecological tumor cell lines, ONCOL REP, 8(6), 2001, pp. 1381-1386
Authors:
Runnebaum, IB
Wang-Gohrke, S
Vesprini, D
Kreienberg, R
Lynch, H
Moslehi, R
Ghadirian, P
Weber, B
Godwin, AK
Risch, H
Garber, J
Lerman, C
Olopade, OI
Foulkes, WD
Karlan, B
Warner, E
Rosen, B
Rebbeck, T
Tonin, P
Dube, MP
Kieback, DG
Narod, SA
Citation: Ib. Runnebaum et al., Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptives, PHARMACOGEN, 11(7), 2001, pp. 635-638
Authors:
Rieber, A
Nussle, K
Stohr, I
Grab, D
Fenchel, S
Kreienberg, R
Reske, SN
Brambs, HJ
Citation: A. Rieber et al., Preoperative diagnosis of ovarian tumors with MR imaging: Comparison with transvaginal sonography, positron emission tomography, and histologic findings, AM J ROENTG, 177(1), 2001, pp. 123-129
Authors:
Schirrmeister, H
Kuhn, T
Guhlmann, A
Santjohanser, C
Horster, T
Nussle, K
Koretz, K
Glatting, G
Rieber, A
Kreienberg, R
Buck, TC
Reske, SN
Citation: H. Schirrmeister et al., Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: comparison with the standard staging procedures, EUR J NUCL, 28(3), 2001, pp. 351-358
Authors:
Rosenbusch, B
Schneider, M
Kreienberg, R
Brucker, C
Citation: B. Rosenbusch et al., Cytogenetic analysis of human zygotes displaying three pronuclei and one polar body after intracytoplasmic sperm injection, HUM REPR, 16(11), 2001, pp. 2362-2367
Authors:
Heuser, T
Rink, T
Weller, E
Fitz, H
Zippel, HH
Kreienberg, R
Kuhn, T
Citation: T. Heuser et al., Impact of the axillary nodal status on sentinel node mapping in breast cancer and its relevance for technical proceeding, BREAST CANC, 67(2), 2001, pp. 125-132
Authors:
Volm, T
Pfaff, P
Gnann, R
Kreienberg, R
Citation: T. Volm et al., Bladder carcinoma associated with cyclophosphamide therapy for ovarian cancer occurring with a latency of 20 years, GYNECOL ONC, 82(1), 2001, pp. 197-199
Authors:
Kreienberg, R
Citation: R. Kreienberg, Adenocarcinoma of the cervix uteri in a 27-year-old patient, GYNAKOLOGE, 34(8), 2001, pp. 758-759
Authors:
Kreienberg, R
Schnurch, HG
Bender, HG
Citation: R. Kreienberg et al., Vulva and vaginal carcinoma, GYNAKOLOGE, 34(7), 2001, pp. 589-589
Authors:
Schirrmeister, H
Kreienberg, R
Reske, SN
Kuhn, T
Citation: H. Schirrmeister et al., Positron emission tomography in breast cancer, GEBURTSH FR, 61(6), 2001, pp. 351-354
Authors:
Kuhn, T
Vogl, FD
Santjohanser, C
Kotzerke, J
Schirrmeister, H
Grimm, S
Koretz, K
Kreienberg, R
Citation: T. Kuhn et al., Sentinel-node-biopsy in breast cancer - Results from a multicenter trial, GEBURTSH FR, 61(6), 2001, pp. 376-383
Authors:
Kuehn, T
Santjohanser, C
Grab, D
Klauss, W
Koretz, K
Kreienberg, R
Citation: T. Kuehn et al., Endoscopic axillary surgery in breast cancer, BR J SURG, 88(5), 2001, pp. 698-703
Authors:
Groten, T
Kreienberg, R
Fialka, I
Huber, L
Wedlich, D
Citation: T. Groten et al., Altered subcellular distribution of cadherin-5 in endothelial cells causedby the serum of pre-eclamptic patients, MOL HUM REP, 6(11), 2000, pp. 1027-1032
Authors:
Stickeler, E
Vogl, FD
Denkinger, T
Mobus, VJ
Kreienberg, R
Runnebaum, IB
Citation: E. Stickeler et al., Soluble CD44 splice variants and pelvic lymph node metastasis in ovarian cancer patients, INT J MOL M, 6(5), 2000, pp. 595-601
Complete resection of adnexal masses with endobag extraction: the risk of involuntary tumour rupture
Authors:
Kuhn, T
Mangold, R
Santjohanser, C
Heuser, T
Hock, S
Zippel, HH
Kreienberg, R
Citation: T. Kuhn et al., Complete resection of adnexal masses with endobag extraction: the risk of involuntary tumour rupture, GYNAEC ENDO, 9(1), 2000, pp. 59-63
Authors:
Grab, D
Paulus, WE
Erdmann, M
Terinde, R
Oberhoffer, R
Lang, D
Muche, R
Kreienberg, R
Citation: D. Grab et al., Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial, ULTRASOUN O, 15(1), 2000, pp. 19-27
Authors:
Kuehn, T
Kreienberg, R
Citation: T. Kuehn et R. Kreienberg, Sentinel node mapping in gynecologic malignancies, ARCH GYN OB, 264(3), 2000, pp. 113-115
Authors:
Kuhn, T
Santjohanser, C
Koretz, K
Bohm, W
Kreienberg, R
Citation: T. Kuhn et al., Axilloscopy and endoscopic sentinel node detection in breast cancer patients, SURG ENDOSC, 14(6), 2000, pp. 573-577
Authors:
Kuhn, T
Kreienberg, R
Citation: T. Kuhn et R. Kreienberg, Surgical treatment of breast cancer - Current status and new concepts, ONKOLOGIE, 23(6), 2000, pp. 524-525
Authors:
Kuhn, T
Santjohanser, C
Koretz, K
Kreienberg, R
Citation: T. Kuhn et al., Sentinel node biopsy in breast cancer, ONKOLOGIE, 23(2), 2000, pp. 121-126
Authors:
Kreienberg, R
Citation: R. Kreienberg, The role of anthracyclines in the treatment of breast and ovarian cancer -Introduction, ONKOLOGIE, 23, 2000, pp. 1-2
Authors:
Wu, Q
Kreienberg, R
Runnebaum, IB
Citation: Q. Wu et al., Growth suppression of human ovarian carcinoma OV-MZ-2a and OV-MZ-32 cells mediated by gene transfer of wild-type p53 enhanced by chemotherapy in vitro, J CANC RES, 126(3), 2000, pp. 139-144